Invesco Ltd. Has $9.06 Million Stock Position in Astrana Health, Inc. $ASTH

Key Points

• Invesco Ltd. increased its holdings in Astrana Health, Inc. by 13.0%, acquiring an additional 33,523 shares for a total of 292,043 shares valued at approximately $9 million.
• Astrana Health reported a net margin of 1.04% with a year-over-year revenue increase of 34.7%, although its earnings per share (EPS) of $0.19 missed analysts' estimates of $0.36.
• The company has a market cap of $1.72 billion and is expected to post an EPS of 1.15 for the current fiscal year, according to sell-side analysts.

Invesco Ltd. increased its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 13.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 292,043 shares of the company's stock after purchasing an additional 33,523 shares during the quarter. Invesco Ltd. owned approximately 0.52% of Astrana Health worth $9,056,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ASTH. Quarry LP increased its position in Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after purchasing an additional 471 shares in the last quarter. Covestor Ltd increased its position in Astrana Health by 777.6% during the 1st quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after purchasing an additional 1,773 shares in the last quarter. US Bancorp DE increased its position in Astrana Health by 21.3% during the 1st quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after purchasing an additional 1,015 shares in the last quarter. PharVision Advisers LLC acquired a new position in Astrana Health during the 4th quarter worth approximately $211,000. Finally, Envestnet Asset Management Inc. increased its position in Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after acquiring an additional 1,184 shares during the period. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Trading Up 2.0%

NASDAQ ASTH traded up $0.63 on Friday, hitting $31.96. The company's stock had a trading volume of 358,021 shares, compared to its average volume of 501,014. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52. Astrana Health, Inc. has a 1-year low of $21.20 and a 1-year high of $63.20. The company's 50-day moving average is $25.91 and its 200 day moving average is $28.41. The firm has a market cap of $1.79 billion, a PE ratio of 62.67, a PEG ratio of 0.79 and a beta of 0.85.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The business had revenue of $654.81 million during the quarter, compared to analyst estimates of $639.13 million. During the same quarter last year, the company posted $0.40 earnings per share. The company's revenue was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. As a group, analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.